Veeva Systems delivered a solid fourth quarter and a strong fiscal year finish, underscoring durable demand for its Vault platform across life sciences workflows. Q4 2025 revenue of $720.9 million captured broad-based strength in R&D and commercial segments, with gross margin of approximately 74.9% and non-GAAP operating margin of 26.1%. Net income of $195.6 million and earnings per share of $1.20 (GAAP/nongaap) reflect disciplined cost management alongside continued investment in product innovation. For the full year, revenue reached $2.75 billion with non-GAAP operating income of roughly $1.15 billion. Management reiterated a strategy pivot toward AI-enabled workflows and data products, highlighted by the accelerated data-cloud agenda (Compass, OpenData, Pulse) and an expanding Vault CRM footprint among the top 20 customers. The company also reaffirmed its longer-term ambition, including a 2030 revenue target of $6 billion, and signaled that the vast majority of top-20 Vault CRM commitments are expected to occur by 2026. Liquidity remains robust, with substantial net cash generation and a healthy balance sheet, supporting continued investments in product development and go-to-market execution. Investors should monitor (i) the pace of top-20 CRM commitments and data-cloud expansion, (ii) AI-enabled product adoption (CRM Bot, MLR Bot, eTMF/CTMS enhancements), and (iii) potential macro-driven delays in enterprise IT projects, though management contends life sciences remains comparatively resilient to near-term cycles.